Vivos Therapeutics (VVOS) Current Leases (2021 - 2025)
Historic Current Leases for Vivos Therapeutics (VVOS) over the last 5 years, with Q3 2025 value amounting to $734000.0.
- Vivos Therapeutics' Current Leases rose 5134.02% to $734000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $734000.0, marking a year-over-year increase of 5134.02%. This contributed to the annual value of $477000.0 for FY2024, which is 63.29% up from last year.
- Per Vivos Therapeutics' latest filing, its Current Leases stood at $734000.0 for Q3 2025, which was up 5134.02% from $654000.0 recorded in Q2 2025.
- In the past 5 years, Vivos Therapeutics' Current Leases registered a high of $734000.0 during Q3 2025, and its lowest value of $72000.0 during Q4 2021.
- In the last 5 years, Vivos Therapeutics' Current Leases had a median value of $463500.0 in 2023 and averaged $454687.5.
- As far as peak fluctuations go, Vivos Therapeutics' Current Leases surged by 48194.44% in 2022, and later tumbled by 331.26% in 2025.
- Over the past 5 years, Vivos Therapeutics' Current Leases (Quarter) stood at $72000.0 in 2021, then surged by 481.94% to $419000.0 in 2022, then grew by 13.13% to $474000.0 in 2023, then increased by 0.63% to $477000.0 in 2024, then skyrocketed by 53.88% to $734000.0 in 2025.
- Its Current Leases stands at $734000.0 for Q3 2025, versus $654000.0 for Q2 2025 and $467000.0 for Q1 2025.